A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study.
about
Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.Eravacycline for treatment of complicated intra-abdominal infections: the fire is not ignited!What's new in pharmacokinetics of antimicrobials in AKI and RRT?Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A high-dose aminoglycoside reg ...... ens: a proof-of-concept study.
@en
type
label
A high-dose aminoglycoside reg ...... ens: a proof-of-concept study.
@en
prefLabel
A high-dose aminoglycoside reg ...... ens: a proof-of-concept study.
@en
P2093
P2860
P356
P1476
A high-dose aminoglycoside reg ...... gens: a proof-of-concept study
@en
P2093
Alexandre Brasseur
Fabio Silvio Taccone
Frédéric Cotton
Frédérique Jacobs
Maya Hites
Sandrine Roisin
P2860
P304
P356
10.1093/JAC/DKV491
P407
P577
2016-01-31T00:00:00Z